IRM
Overvalued by 130.6% based on the discounted cash flow analysis.
Market cap | $23.24 Billion |
---|---|
Enterprise Value | $35.76 Billion |
Dividend Yield | $2.5346 (3.2%) |
Earnings per Share | $0.66 |
Beta | 1.1 |
Outstanding Shares | 293,133,321 |
Avg 30 Day Volume | 1,352,968 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 119.98 |
---|---|
PEG | 818.71 |
Price to Sales | 4.19 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 6.34 |
Enterprise Value to EBIT | 31.41 |
Enterprise Value to Net Income | 184 |
Total Debt to Enterprise | 0.36 |
Debt to Equity | 685.59 |
No data
No data